Hiroki Shirato mainly focuses on Radiation therapy, Nuclear medicine, Radiation treatment planning, Surgery and Radiology. Hiroki Shirato works in the field of Radiation therapy, focusing on Tumor tracking in particular. His study in Nuclear medicine is interdisciplinary in nature, drawing from both Fluoroscopy, Tomography, Lung and Fiducial marker.
His Radiation treatment planning research incorporates elements of Organ Motion, Prostate and Prostate cancer. His Surgery study frequently draws connections between related disciplines such as Internal medicine. His research on Radiology focuses in particular on Magnetic resonance imaging.
Hiroki Shirato mainly investigates Radiation therapy, Nuclear medicine, Radiology, Surgery and Internal medicine. His Radiation therapy research is multidisciplinary, incorporating elements of Survival rate, Medical physics and Chemotherapy. He studied Nuclear medicine and Magnetic resonance imaging that intersect with Pathology.
His research on Radiology frequently connects to adjacent areas such as Lung cancer. His research in Surgery is mostly focused on Concomitant. His studies deal with areas such as Gastroenterology and Oncology as well as Internal medicine.
His primary scientific interests are in Nuclear medicine, Radiation therapy, Radiology, Proton therapy and Beam. His Nuclear medicine study incorporates themes from Radiation treatment planning, Head and neck squamous-cell carcinoma, Fluoroscopy, Fiducial marker and Magnetic resonance imaging. As part of his studies on Radiation therapy, Hiroki Shirato often connects relevant areas like Oncology.
His Radiology study combines topics in areas such as Lung cancer and Lung. Hiroki Shirato works mostly in the field of Proton therapy, limiting it down to concerns involving Imaging phantom and, occasionally, Computer vision and Artificial intelligence. The various areas that Hiroki Shirato examines in his Beam study include Range, Irradiation, Synchrotron and Proton.
His main research concerns Nuclear medicine, Radiation therapy, Radiology, Magnetic resonance imaging and Proton therapy. His Nuclear medicine research is multidisciplinary, relying on both Stereotactic body radiation therapy, Blood flow, Head and neck squamous-cell carcinoma, Head and neck cancer and Fiducial marker. His Fiducial marker research is multidisciplinary, incorporating perspectives in Fluoroscopy, Gating, Tumor tracking and Image-guided radiation therapy.
Radiation therapy is closely attributed to Oncology in his work. The study incorporates disciplines such as Survival rate, Multivariate analysis, Univariate analysis and Neuroradiology in addition to Radiology. His work deals with themes such as Treatment outcome, Breast cancer, Intraclass correlation and Pathology, which intersect with Magnetic resonance imaging.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Stereotactic Radiosurgery Plus Whole-Brain Radiation Therapy vs Stereotactic Radiosurgery Alone for Treatment of Brain Metastases: A Randomized Controlled Trial
Hidefumi Aoyama;Hiroki Shirato;Masao Tago;Keiichi Nakagawa.
JAMA (2006)
Precise and real-time measurement of 3D tumor motion in lung due to breathing and heartbeat, measured during radiotherapy.
Yvette Seppenwoolde;Hiroki Shirato;Kei Kitamura;Shinichi Shimizu.
International Journal of Radiation Oncology Biology Physics (2002)
Hypofractionated stereotactic radiotherapy (HypoFXSRT) for stage I non-small cell lung cancer: updated results of 257 patients in a Japanese multi-institutional study.
Hiroshi Onishi;Hiroki Shirato;Yasushi Nagata;Masahiro Hiraoka.
Journal of Thoracic Oncology (2007)
Physical aspects of a real-time tumor-tracking system for gated radiotherapy
Hiroki Shirato;Shinichi Shimizu;Tatsuya Kunieda;Kei Kitamura.
International Journal of Radiation Oncology Biology Physics (2000)
Stereotactic body radiotherapy (SBRT) for operable Stage i non-small-cell lung cancer: Can SBRT be comparable to surgery?
Hiroshi Onishi;Hiroki Shirato;Yasushi Nagata;Masahiro Hiraoka.
International Journal of Radiation Oncology Biology Physics (2011)
The management of imaging dose during image-guided radiotherapy: Report of the AAPM Task Group 75
Martin J. Murphy;James Balter;Stephen Balter;Jose A. Bencomo.
Medical Physics (2007)
Four-dimensional treatment planning and fluoroscopic real-time tumor tracking radiotherapy for moving tumor.
Hiroki Shirato;Shinichi Shimizu;Kei Kitamura;Takeshi Nishioka.
International Journal of Radiation Oncology Biology Physics (2000)
Neurocognitive Function of Patients with Brain Metastasis Who Received Either Whole Brain Radiotherapy Plus Stereotactic Radiosurgery or Radiosurgery Alone
Hidefumi Aoyama;Masao Tago;Norio Kato;Tatsuya Toyoda.
International Journal of Radiation Oncology Biology Physics (2007)
Prediction of respiratory tumour motion for real-time image-guided radiotherapy
Gregory C Sharp;Steve B Jiang;Shinichi Shimizu;Hiroki Shirato.
Physics in Medicine and Biology (2004)
Intrafractional tumor motion: lung and liver.
Hiroki Shirato;Yvette Seppenwoolde;Kei Kitamura;Rikiya Onimura.
Seminars in Radiation Oncology (2004)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Kyoto Prefectural University of Medicine
Stanford University
Kyoto University
The University of Texas Southwestern Medical Center
Hokkaido University
Harvard University
Nagoya University
Stanford University
Osaka Metropolitan University
Google (United States)
University of California, Berkeley
Tsinghua University
University of Paris-Saclay
Jawaharlal Nehru Centre for Advanced Scientific Research
University of Nevada, Las Vegas
Boston University
Technical University of Denmark
University of Montpellier
University of Massachusetts Dartmouth
Stanford University
Reithera
Arizona State University
Yale University
United States Department of Defense
Loyola University Chicago